Literature DB >> 2823823

Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines.

Y Pommier1, J Covey, D Kerrigan, W Mattes, J Markovits, K W Kohn.   

Abstract

An attempt was made to analyze the mechanism by which 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) inhibits mammalian DNA topoisomerase II. The effects of various 9-aminoacridine derivatives differing by their DNA affinities and DNA sequence selectivity of binding were compared in the presence of purified mouse leukemia L1210 DNA topoisomerase II. No correlation was found between DNA unwinding and topoisomerase II inhibition. 9-Aminoacridine was inactive as a topoisomerase II inhibitor and o-AMSA was only weakly active. The location of L1210 topoisomerase II mediated DNA breaks produced in the absence or presence of 9-aminoacridines were studied in [32P]-end-labeled pBR 322 DNA. All 9-aminoacridines, even those differing by their DNA sequence selectivity of binding, produced similar DNA cleavage patterns. Most drug-induced topoisomerase II mediated DNA breaks appeared at sites that were already cleaved by the enzyme in the absence of drug. The present results suggest that 9-aminoacridines inhibit L1210 DNA topoisomerase II by interacting at or near enzyme-DNA complexes by some unknown DNA effect or by direct protein interaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823823     DOI: 10.1016/0006-2952(87)90329-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Thermodynamics of the interactions of m-AMSA and o-AMSA with nucleic acids: influence of ionic strength and DNA base composition.

Authors:  R M Wadkins; D E Graves
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

2.  A consensus sequence for cleavage by vertebrate DNA topoisomerase II.

Authors:  J R Spitzner; M T Muller
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

Review 3.  DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.

Authors:  Y Pommier
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.

Authors:  C Jaxel; K W Kohn; Y Pommier
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

5.  Novel therapeutic compound acridine-retrotuftsin action on biological forms of melanoma and neuroblastoma.

Authors:  Miroslawa Cichorek; Anna Ronowska; Monika Gensicka-Kowalewska; Milena Deptula; Iwona Pelikant-Malecka; Krystyna Dzierzbicka
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-26       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.